Drug Shortage Prevention Act of 2025
In committee: it can still change before the session ends.
- Stage
- In committee
- Started in
- Senate
- Sponsors
- 6
- Latest action
- Aug 1, 2025
What it does
The Drug Shortage Prevention Act of 2025 would amend the Federal Food, Drug, and Cosmetic Act to require manufacturers of critical drugs to notify the Secretary of Health and Human Services of potential supply disruptions—including increased demand, export restrictions, or manufacturing interruptions—within specific timeframes, with detailed information about causes, alternative sources, and expected duration. It defines “covered drugs” as life-supporting, life-sustaining, or critical public health medications (excluding biologics and radiopharmaceuticals unless otherwise specified) and mandates more frequent reporting on drug supply chains, including supplier details for active…
No official summary is available here. This one was written by AI from the bill’s text.
Where it stands
Introduced (Done)
Committee (Current step)
Floor (Not started)
Law (Not started)
What moved
Who is involved
Sponsors
The lawmakers who put their names on it, lead sponsors first.
Where it goes next
While a bill can still move, the questions are about people and money.